Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/10/21 16:35 | 6/9/21 | CHRS | Health | BioPrd | Biological Products, (No Diag | Stilwell McDavid | CA | O | CFO | P | 50 | 13.42 | 0 | 4 | 12 | 35 | D | ||||||||||||||
11/12/14 12:03 | 11/12/14 | CHRS | Health | BioPrd | Biological Products, (No Diag | Healy James | CA | D | P.d | 5,750 | 13.50 | 0 | 426 | 20 | 2,558 | M | |||||||||||||||
11/12/14 11:50 | 11/12/14 | CHRS | Health | BioPrd | Biological Products, (No Diag | Lilly Eli & Co | IN | H | Former 1 | P.d | 2,227 | 13.50 | 0 | 165 | 6 | 3,042 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |